{"id":23896,"date":"2014-05-16T12:51:17","date_gmt":"2014-05-16T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23896"},"modified":"2018-04-14T02:10:24","modified_gmt":"2018-04-14T07:10:24","slug":"23896","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23896\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 16 de maio de 2014"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_5-16-14.pdf\">vers\u00e3o impressa<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas sobre sa\u00fade animal de 16 de maio de 2014<\/strong><br \/>\nCopyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon DVM MBA<br \/>\n************************************<br \/>\nNAS NOTICIAS:<br \/>\n&nbsp;<br \/>\n<u>Novidades da Brakke Consulting<br \/>\n<\/u>AnimalHealthJobs.com <br \/>\n&nbsp;<br \/>\n<u>not\u00edcias de ganhos<\/u><br \/>\nImmuCellName <br \/>\nBioci\u00eancias afins<br \/>\nFibro Sa\u00fade Animal<br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<br \/>\n<\/u>Abaxis<br \/>\nAnimedica<br \/>\nceva<br \/>\nCross VetPharm<br \/>\nElanco<br \/>\nInd\u00fastria Italiana Integradora Trei<br \/>\nPBI-Gordon<br \/>\nAlimentos e suprimentos para animais de estima\u00e7\u00e3o Phillips<br \/>\nVCA Antech<br \/>\nWolverton<br \/>\nZoetis<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nANIMALHEALTHJOBS.COM<br \/>\n<\/strong>&nbsp;<br \/>\nO melhor lugar na web para encontrar candidatos qualificados!<\/p>\n<p><a href=\"http:\/\/www.AnimalHealthJobs.com\">www.AnimalHealthJobs.com<\/a> \u00e9 o principal site de recrutamento para a ind\u00fastria de sa\u00fade animal.<\/p>\n<p>Quando precisar de profissionais qualificados, pense primeiro na Brakke Consultoria e Sa\u00fade Animal.<\/p>\n<p><a href=\"http:\/\/www.AnimalHealthJobs.com\">www.AnimalHealthJobs.com<\/a>&nbsp; <br \/>\n&nbsp;<br \/>\n************************************<br \/>\nRELEASES DE RESULTADOS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Phibro Animal Health Corporation divulgou seus resultados financeiros do terceiro trimestre fiscal de mar\u00e7o de 2014. As vendas l\u00edquidas foram de $173 milh\u00f5es, um aumento de 7%. As vendas de Sa\u00fade Animal cresceram 15% para $108 milh\u00f5es. (Wall Street Journal)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Kindred Biosciences, Inc. anunciou resultados financeiros para o trimestre encerrado em 31 de mar\u00e7o de 2014. A empresa sofreu um preju\u00edzo l\u00edquido de ($6,2 milh\u00f5es) no trimestre em compara\u00e7\u00e3o com um preju\u00edzo l\u00edquido de ($224.000) no trimestre encerrado em mar\u00e7o. 31 de outubro de 2013. A Empresa concluiu uma oferta p\u00fablica subsequente em abril, levantando aproximadamente $58,1 milh\u00f5es em receitas l\u00edquidas. (PRNewswire)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A ImmuCell Corporation anunciou os resultados financeiros do primeiro trimestre de 2014. As vendas de produtos foram de $2,1 milh\u00f5es, um aumento de 13% em compara\u00e7\u00e3o com o mesmo per\u00edodo do ano anterior. O preju\u00edzo l\u00edquido foi ($13.000) em compara\u00e7\u00e3o com o lucro l\u00edquido de $204.000 durante o primeiro trimestre de 2013. (comunicado \u00e0 imprensa da empresa)&nbsp;&nbsp; <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Elanco anunciou que recebeu a aprova\u00e7\u00e3o da FDA para o Pulmotil AC (concentrado aquoso de tilmicosina) para o controle da doen\u00e7a respirat\u00f3ria su\u00edna associada a Pasteurella multocida e Haemophilus parasuis. (FDA)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A Ceva anunciou que recebeu a aprova\u00e7\u00e3o da FDA para Tildren (tiludronato diss\u00f3dico) para infus\u00e3o intravenosa para o controle de sinais cl\u00ednicos associados \u00e0 s\u00edndrome navicular em cavalos. (FDA) <br \/>\n&nbsp;<br \/>\n&gt; A Cross VetPharm anunciou que o FDA aprovou novos pedidos abreviados de medicamentos para animais (ANADA) para GentaMed-P (sulfato de gentamicina injet\u00e1vel) para uso em galinhas e perus, e Xylamed (xilazina injet\u00e1vel) para uso em cavalos e cerv\u00eddeos. (FDA) <br \/>\n&nbsp;<br \/>\n&gt; VCA Inc. e Abaxis, Inc. anunciaram conjuntamente que celebraram dois acordos de longo prazo, o primeiro um acordo de fornecimento de produtos de longo prazo para os Hospitais de Animais da VCA e o segundo um acordo de co-marketing com os laborat\u00f3rios de refer\u00eancia Antech Diagnostic da VCA. Sob o acordo de fornecimento de produtos de longo prazo, a VCA adquirir\u00e1 analisadores qu\u00edmicos VetScan VS2 e discos de reagentes de diagn\u00f3stico da Abaxis para coloca\u00e7\u00e3o na maioria dos mais de 600 hospitais veterin\u00e1rios da VCA localizados na Am\u00e9rica do Norte. (comunicado de imprensa da empresa)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A PBI-Gordon anunciou que estabeleceu o PBI-Gordon Well Animal Group, uma nova divis\u00e3o que inclui as marcas Lambert-Kay, Trophy, Gordon&#039;s e PetAg. (Neg\u00f3cio de animais de estima\u00e7\u00e3o)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; A Phillips Pet Food and Supplies anunciou que adquiriu a distribuidora de animais de estima\u00e7\u00e3o do meio-oeste Wolverton. Os termos financeiros n\u00e3o foram divulgados. (Neg\u00f3cio de animais de estima\u00e7\u00e3o) <br \/>\n&nbsp;<br \/>\n&gt; JAP\u00c3O A Zoetis anunciou o lan\u00e7amento japon\u00eas do Palladia Tablets 10 (fosfato de toceranib) para o tratamento de mastocitomas cut\u00e2neos recorrentes em c\u00e3es; e infus\u00e3o intramam\u00e1ria de Pirsue (pirlimicina) para o tratamento de mastite bovina causada por Staphylococcus e Streptococcus em vacas lactantes. (Farm\u00e1cia Animal)&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; IT\u00c1LIA Animedica Group GmbH anunciou a aquisi\u00e7\u00e3o da Industria Italiana Integratori Trei SpA, empresa italiana focada em produtos veterin\u00e1rios para animais de cria\u00e7\u00e3o. O volume de neg\u00f3cios da Trei foi de 20 milh\u00f5es de euros ($27 milh\u00f5es), incluindo vendas internacionais em mais de 20 pa\u00edses estrangeiros. Os termos financeiros n\u00e3o foram divulgados. (comunicado de imprensa da empresa)&nbsp; <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 COMPOSI\u00c7\u00c3O DE MEDICAMENTOS EQUINOS A FDA est\u00e1 alertando propriet\u00e1rios de cavalos e veterin\u00e1rios que dois lotes de medicamentos combinados contendo pirimetamina e toltrazuril, usados para tratar Mieloencefalite Protozo\u00e1ria Equina (EPM), foram associados a eventos adversos em dez cavalos. Quatro cavalos morreram ou foram sacrificados e seis cavalos est\u00e3o se recuperando. Os produtos foram manipulados pela Wickliffe Pharmacy de Lexington, Ky. Todos os produtos nesses lotes s\u00e3o contabilizados e n\u00e3o est\u00e3o mais em distribui\u00e7\u00e3o. A FDA est\u00e1 trabalhando com a farm\u00e1cia e parceiros estaduais para investigar esses eventos adversos. (FDA)<br \/>\n&nbsp;<br \/>\n&gt; RESIST\u00caNCIA A ANTIBI\u00d3TICOS A maior pesquisa metagen\u00f4mica de genes de resist\u00eancia a antibi\u00f3ticos nas sequ\u00eancias de DNA de comunidades microbianas de todo o mundo descobriu que bact\u00e9rias portadoras desses genes aparecem em todos os lugares da natureza onde os cientistas os procuram. As an\u00e1lises dos cientistas detectaram determinantes gen\u00e9ticos de resist\u00eancia a antibi\u00f3ticos em todos os 71 ambientes representados nos dados p\u00fablicos, incluindo solo, oceanos e fezes humanas. Amostras coletadas do solo continham o mais diversificado conjunto de genes de resist\u00eancia. As descobertas foram relatadas na revista Cell Press Current Biology. (Alimentos) <br \/>\n&nbsp;<br \/>\n&gt; EUA \u2013 PRODUTOS ORG\u00c2NICOS As vendas de produtos org\u00e2nicos nos EUA saltaram para $35,1 bilh\u00f5es em 2013, um aumento de 11,5% em rela\u00e7\u00e3o ao ano anterior, de acordo com a \u00faltima pesquisa sobre a ind\u00fastria org\u00e2nica da Organic Trade Assn. (OTA). A categoria de frutas e vegetais continua a liderar o setor com $11,6 bilh\u00f5es em vendas; as vendas org\u00e2nicas de carne, aves e peixes aumentaram 11%, para $675 milh\u00f5es. (Alimentos)<br \/>\n&nbsp;<br \/>\n************************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<br \/>\n&nbsp;<br \/>\nAs not\u00edcias desta semana refletem a consolida\u00e7\u00e3o cont\u00ednua que vem ocorrendo h\u00e1 v\u00e1rios anos. As aquisi\u00e7\u00f5es ou fus\u00f5es destinam-se tanto a pequenos fabricantes como a distribuidores de m\u00e9dio porte em diversas \u00e1reas geogr\u00e1ficas. Tamb\u00e9m foi anunciada uma parceria entre dois grandes players da \u00e1rea de diagn\u00f3stico para melhor atender seus clientes.<\/p>\n<p>Durante as \u00faltimas semanas, tivemos diversas intera\u00e7\u00f5es com fabricantes e distribuidores que est\u00e3o vivenciando um aumento na atividade de receita em compara\u00e7\u00e3o com um primeiro trimestre desafiador. Ser\u00e1 que o clima mais quente e as atividades ao ar livre do ver\u00e3o que se aproxima melhorar\u00e3o as atitudes dos donos e produtores de animais de estima\u00e7\u00e3o? T\u00e3o importante como o clima mais quente \u00e9 o aparecimento de pelo menos algumas quantidades razo\u00e1veis de chuva caindo em algumas das \u00e1reas secas dos EUA. Precisaremos de muito mais aqui no Texas para recuperar o atraso, mas tivemos algumas boas chuvas nas \u00faltimas duas semanas que pelo menos nos d\u00e3o alguma esperan\u00e7a.<\/p>\n<p>Tenha um \u00f3timo fim de semana!<\/p>\n<p>Ron Brakke<br \/>\n&nbsp;<br \/>\n**********************************<br \/>\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<br \/>\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n12005 Ford Rd., Suite 530<br \/>\nDallas, TX 75234 EUA<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>vers\u00e3o impressa *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 16 de maio de 2014 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NO NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias sobre ganhos do AnimalHealthJobs.com ImmuCell Kindred Biosciences Phibro Animal Health outras not\u00edcias Abaxis Animedica Ceva Cross VetPharm Elanco Industria Italiana Integratori Trei PBI-Gordon Phillips Pet Food and Supplies VCA Antech Wolverton Zoetis ********** ************************** BRAKKE CONSULTING, INC. ANIMALHEALTHJOBS.COM O melhor lugar na web para encontrar candidatos a empregos qualificados! www.AnimalHealthJobs.com \u00e9 o principal site de recrutamento para a ind\u00fastria de sa\u00fade animal. Quando precisar de profissionais qualificados, pense primeiro na Brakke Consulting e Animal Health Jobs. www.AnimalHealthJobs.com ************************************ DIVULGA\u00c7\u00d5ES DE GANHOS DA EMPRESA&gt; Phibro Animal Health Corporation relatou seus resultados financeiros para o terceiro trimestre fiscal de mar\u00e7o de 2014. As vendas l\u00edquidas foram de $173 milh\u00f5es, um aumento de 7%. As vendas de Sa\u00fade Animal cresceram 15% para $108 milh\u00f5es. (Wall Street Journal) &gt; Kindred Biosciences, Inc. anunciou resultados financeiros para o trimestre encerrado em 31 de mar\u00e7o de 2014. A empresa sofreu um preju\u00edzo l\u00edquido de ($6,2 milh\u00f5es) no trimestre em compara\u00e7\u00e3o com um preju\u00edzo l\u00edquido de ($224.000) para o trimestre encerrado em 31 de mar\u00e7o de 2013. A Empresa concluiu uma oferta p\u00fablica subsequente em abril, levantando aproximadamente $58,1 milh\u00f5es em receitas l\u00edquidas. (PRNewswire) &gt; ImmuCell Corporation anunciou resultados financeiros para o<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23896\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23896","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23896\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 16, 2014 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news AnimalHealthJobs.com &nbsp; earnings news ImmuCell Kindred Biosciences Phibro Animal Health &nbsp; other news Abaxis Animedica Ceva Cross VetPharm Elanco Industria Italiana Integratori Trei PBI-Gordon Phillips Pet Food and Supplies VCA Antech Wolverton Zoetis &nbsp; ************************************ BRAKKE CONSULTING, INC. ANIMALHEALTHJOBS.COM &nbsp; The best place on the web to find qualified job applicants! www.AnimalHealthJobs.com is the premier recruiting web site for the animal health industry. When you need qualified professionals, think of Brakke Consulting and Animal Health Jobs first. www.AnimalHealthJobs.com&nbsp; &nbsp; ************************************ COMPANY EARNINGS RELEASES &nbsp; &gt; Phibro Animal Health Corporation reported its financial results for its March 2014 fiscal third quarter. Net sales were $173 million, an increase of 7%. Animal Health sales grew 15% to $108 million. (Wall Street Journal)&nbsp; &nbsp; &gt; Kindred Biosciences, Inc. announced financial results for the quarter ended March 31, 2014. The Company incurred a net loss of ($6.2 million) for the quarter compared to a net loss of ($224,000) for the quarter ended March 31, 2013. The Company completed a follow-on public offering in April, raising approximately $58.1 million in net proceeds. (PRNewswire)&nbsp; &nbsp; &gt; ImmuCell Corporation announced financial results for theView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23896\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-16T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:10:24+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for May 16, 2014\",\"datePublished\":\"2014-05-16T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:10:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/\"},\"wordCount\":1075,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2014-05-16T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:10:24+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/ja\/23896\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/23896\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for May 16, 2014\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23896\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 16, 2014 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news AnimalHealthJobs.com &nbsp; earnings news ImmuCell Kindred Biosciences Phibro Animal Health &nbsp; other news Abaxis Animedica Ceva Cross VetPharm Elanco Industria Italiana Integratori Trei PBI-Gordon Phillips Pet Food and Supplies VCA Antech Wolverton Zoetis &nbsp; ************************************ BRAKKE CONSULTING, INC. ANIMALHEALTHJOBS.COM &nbsp; The best place on the web to find qualified job applicants! www.AnimalHealthJobs.com is the premier recruiting web site for the animal health industry. When you need qualified professionals, think of Brakke Consulting and Animal Health Jobs first. www.AnimalHealthJobs.com&nbsp; &nbsp; ************************************ COMPANY EARNINGS RELEASES &nbsp; &gt; Phibro Animal Health Corporation reported its financial results for its March 2014 fiscal third quarter. Net sales were $173 million, an increase of 7%. Animal Health sales grew 15% to $108 million. (Wall Street Journal)&nbsp; &nbsp; &gt; Kindred Biosciences, Inc. announced financial results for the quarter ended March 31, 2014. The Company incurred a net loss of ($6.2 million) for the quarter compared to a net loss of ($224,000) for the quarter ended March 31, 2013. The Company completed a follow-on public offering in April, raising approximately $58.1 million in net proceeds. (PRNewswire)&nbsp; &nbsp; &gt; ImmuCell Corporation announced financial results for theView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23896\/","og_site_name":"Brakke Consulting Website","article_published_time":"2014-05-16T17:51:17+00:00","article_modified_time":"2018-04-14T07:10:24+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/ja\/23896\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/23896\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for May 16, 2014","datePublished":"2014-05-16T17:51:17+00:00","dateModified":"2018-04-14T07:10:24+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/ja\/23896\/"},"wordCount":1075,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/ja\/23896\/","url":"https:\/\/brakkeconsulting.com\/ja\/23896\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2014-05-16T17:51:17+00:00","dateModified":"2018-04-14T07:10:24+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/ja\/23896\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/ja\/23896\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/ja\/23896\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for May 16, 2014"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23896"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23896\/revisions"}],"predecessor-version":[{"id":25482,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23896\/revisions\/25482"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}